However, the evidence regarding the capacity of more recent serum biomarkers, including interleukin-6 (IL-6), to discriminate between complicated and uncomplicated PAA is scarce. The gene discussed is IL6; the disease is pulmonary artery-aorta diameter ratio measurement.